A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Lorenzo M. Refolo; Miguel A. Pappolla; John J. LaFrancois; Brian Malester; Stephen D. Schmidt; Tara Thomas-Bryant; G S Tint; R. Wang; Marc Mercken; Suzana Petanceska; Karen Duff

doi:10.1006/nbdi.2001.0422

A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Lorenzo M. Refolo(Nathan Kline Institute for Psychiatric Research), Miguel A. Pappolla(University of South Alabama Medical Center), John J. LaFrancois(Nathan Kline Institute for Psychiatric Research), Brian Malester(Nathan Kline Institute for Psychiatric Research), Stephen D. Schmidt(Nathan Kline Institute for Psychiatric Research), Tara Thomas-Bryant(University of South Alabama Medical Center), G S Tint(Veterans Biomedical Research Institute), R. Wang(Rockefeller University), Marc Mercken(Janssen (Belgium)), Suzana Petanceska(Nathan Kline Institute for Psychiatric Research), Karen Duff(Nathan Kline Institute for Psychiatric Research)

Neurobiology of Disease

October 1, 2001

10.1006/nbdi.2001.0422

Cited by 520Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis